Agilent (A) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates

Core Viewpoint - Analysts expect Agilent Technologies to report quarterly earnings of $1.19 per share, reflecting a year-over-year decline of 6.3%, with revenues projected at $1.58 billion, down 8% from the previous year [1] Revenue Estimates by End Markets - Revenue from Pharmaceutical and Biopharmaceutical markets is expected to reach $569.13 million, indicating a year-over-year decline of 7% [2] - Revenue from Academia and Government markets is projected at $149.56 million, reflecting a decrease of 5.9% from the prior year [2] - Revenue from Diagnostics and Clinical markets is forecasted to be $236.72 million, showing a decline of 5.3% year-over-year [2] - Revenue from Chemical and Advanced Materials markets is estimated at $341.50 million, indicating a decrease of 9.7% from the previous year [3] - Revenue from Environmental and Forensics markets is expected to be $151.91 million, reflecting a year-over-year decline of 3.2% [3] - Revenue from Food markets is projected at $146.20 million, indicating a decrease of 9.2% from the year-ago quarter [4] Net Revenue Estimates - Net Revenue from Agilent Crosslab Group is expected to reach $396.15 million, indicating a year-over-year increase of 2.4% [3] - Net Revenue from Life Sciences and Applied Markets Group is projected at $749.78 million, reflecting a significant decline of 22.5% year-over-year [3] - Net Revenue from Diagnostics and Genomics Group is estimated at $433.43 million, indicating a year-over-year increase of 19.7% [3] Stock Performance - Agilent shares have increased by 11.2% over the past month, outperforming the Zacks S&P 500 composite, which rose by 6.1% [4]